EP. 1: Dr John Brandsema Highlights Progress in SMA Treatment and Improved Outcomes for Patients
July 26th 2022
The introduction of 3 FDA-approved therapies for spinal muscular atrophy is enabling clinicians to treat the disease completely different from how it was handled in the past.